GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novomics Co Ltd (XKRX:283100) » Definitions » ROE % Adjusted to Book Value

Novomics Co (XKRX:283100) ROE % Adjusted to Book Value : 0.00% (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Novomics Co ROE % Adjusted to Book Value?

Novomics Co's ROE % for the quarter that ended in Dec. 2023 was 0.00%. Novomics Co's PB Ratio for the quarter that ended in Dec. 2023 was N/A. Novomics Co's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was N/A.

Novomics Co ROE % Adjusted to Book Value Historical Data

The historical data trend for Novomics Co's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novomics Co ROE % Adjusted to Book Value Chart

Novomics Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial - - - - -

Novomics Co Semi-Annual Data
Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value Get a 7-Day Free Trial - - - - -

Competitive Comparison of Novomics Co's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Novomics Co's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Novomics Co's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Novomics Co's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Novomics Co's ROE % Adjusted to Book Value falls into.


';

Novomics Co ROE % Adjusted to Book Value Calculation

Novomics Co's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

Novomics Co's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novomics Co ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Novomics Co's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Novomics Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novomics Co Ltd (XKRX:283100) » Definitions » ROE % Adjusted to Book Value
Comparable Companies
XKRX:299480 XKRX:066830 XKRX:266470 XKRX:341170 XKRX:244460 XKRX:179530 XKRX:188260 XKRX:344860 XKRX:251280 XKRX:322970 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
171 Dangsan-ro, 304, 305, 306, 306-1, Yeongdeungpo-gu, Seoul, KOR
Website
http://www.novomics.com
Novomics Co Ltd is a developer of a molecular diagnosis system for cancer treatment.

Novomics Co Headlines

No Headlines